HEZAREH M ET AL: "Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 75, no. 24, 1 December 2001 (2001-12-01), pages 12161 - 12168, XP002339184, ISSN: 0022-538X, DOI: 10.1128/JVI.75.24.12161-12168.2001 (B1)

JING LI: "Phase I trial of a humanized, Fc receptor nonbinding anti-CD3 antibody, hu12F6mu in patients receiving renal allografts", MABS, vol. 2, no. 4, 10 August 2010 (2010-08-10), pages 449 - 556, XP055101687 (B1)

LI BOHUA ET AL: "Construction and characterization of a humanized anti-human CD3 monoclonal antibody 12F6 with effective immunoregulation functions", IMMUNOLOGY, BLACKWELL PUBLISHING, OXFORD, GB, vol. 116, no. 4, 1 December 2005 (2005-12-01), pages 487 - 498, XP002600947, ISSN: 0019-2805, [retrieved on 20051007], DOI: 10.1111/J.1365-2567.2005.02247.X (B1)

WOODLE E STEVE ET AL: "Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection", TRANSPLANTATION, WILLIAMS AND WILKINS, BALTIMORE US, vol. 68, no. 5, 15 September 1999 (1999-09-15), pages 608 - 616, XP009134473, ISSN: 0041-1337 (B1)

WO-A1-2012/113813 (B1)

WO-A2-2012/143524 (B1)

LUIS E. HINOJOSA ET AL: "Construction of a Recombinant Non-Mitogenic Anti-Human CD3 Antibody", HYBRIDOMA, vol. 29, no. 2, 1 April 2010 (2010-04-01), pages 115 - 124, XP055101580, ISSN: 1554-0014, DOI: 10.1089/hyb.2009.0042 (B1)